GAM Holding AG Sells 1,406 Shares of Danaher Co. (NYSE:DHR)

GAM Holding AG trimmed its position in shares of Danaher Co. (NYSE:DHR) by 9.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,916 shares of the conglomerate’s stock after selling 1,406 shares during the period. GAM Holding AG’s holdings in Danaher were worth $2,965,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. Heck Capital Advisors LLC bought a new stake in Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 1.5 %

NYSE DHR opened at $206.66 on Tuesday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market cap of $149.26 billion, a P/E ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The stock’s fifty day moving average price is $229.53 and its 200-day moving average price is $249.13.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the company earned $2.09 EPS. As a group, equities analysts forecast that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Danaher’s payout ratio is 20.45%.

Wall Street Analysts Forecast Growth

DHR has been the topic of several research analyst reports. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Scotiabank assumed coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target on the stock. Royal Bank of Canada restated an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Finally, Citigroup cut their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.